Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment.
Kivisäkk P, Carlyle BC, Sweeney T, Trombetta BA, LaCasse K, El-Mufti L, Tuncali I, Chibnik LB, Das S, Scherzer CR, Johnson KA, Dickerson BC, Gomez-Isla T, Blacker D, Oakley DH, Frosch MP, Hyman BT, Aghvanyan A, Bathala P, Campbell C, Sigal G, Stengelin M, Arnold SE.
Kivisäkk P, et al. Among authors: hyman bt.
Front Neurol. 2023 Mar 2;14:1069411. doi: 10.3389/fneur.2023.1069411. eCollection 2023.
Front Neurol. 2023.
PMID: 36937522
Free PMC article.